Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
and JavaScript.
Early results promise a one-off treatment, but gene-editing and gene therapies will have to show durable protection and be affordable to the many patients with sickle cell disease in the world.
A summer pipeline program provides under-represented students from around the United States with exposure and first-hand training to advance their careers in the biotechnology industry.
With supply-chain shortages and production problems exacerbating vaccine inequity, global manufacturing must expand to ensure the world’s poorest nations are better served.
Scientists are using new tools to mine the non-coding part of the genome, known as ‘dark matter’, to uncover disease-linked changes in promoters, silencers and enhancers for target discovery.
A trainee-run group that provides editing and schema design services not only enhances scientific communication for clients, but also trains its members in communication, writing and other transferrable skills.
A study of the brain–machine interface patent landscape suggests that the technology is in its early stages of development, but patent applications have been increasing exponentially in recent years.